Connect your AI

NeoGenomics NEO Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

Tempus AI, Inc.TEM

——

BillionToOne, Inc. BLLN

——

Other financials

Income statement

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NeoGenomics's accrued progress collections and price adjustments?: NeoGenomics (NEO) reported accrued progress collections and price adjustments of $338K in Q1 2026.
How has NeoGenomics's accrued progress collections and price adjustments changed year-over-year?: NeoGenomics's accrued progress collections and price adjustments increased by 13.0% year-over-year, from $299K to $338K.